The results of a secondary analysis of the SCOT-HEART trial show that coronary computed tomography angiography (CCTA) leads to a more appropriate and effective selection of invasive coronary angiography for patients with suspected angina due to coronary heart disease.

In a study appearing in the April 26 issue of JAMA, researchers examined the content, readability and understandability of dense breast notifications sent to women following screening mammography.

April 26, 2016 — Repeated head impacts to high school football players cause measurable changes in their brains, even when no concussion occurs, according to new research. The study was conducted by University of Texas Southwestern Medical Center’s Peter O’Donnell Jr. Brain Institute and Wake Forest University School of Medicine.

Philips announced that any hospital or healthcare facility with one of its indicated computed tomography (CT) models can now become a lung cancer screening center.

A new study from Elizabeth A. Rafferty, M.D., formerly of Massachusetts General Hospital, and colleagues evaluated the screening performance of digital mammography combined with tomosynthesis compared with digital mammography alone for women with varying levels of breast density.

Oklahoma Gov. Mary Fallin signed HB2601 into law, making the Oklahoma the 26th state to report a patient's breast tissue composition through the mammography reporting results. 

The Federal Trade Commission (FTC) announced that it has created a Web-based guidance tool for developers of health-related mobile applications (health apps).

The American Society of Radiologic Technologists (ASRT) has launched Vascular Interventional Essentials, a new educational program that explores the image-guided procedures of interventional radiology.

April 25, 2016 — Doctors and scientists at the University of Southampton have used advanced 3-D X-ray imaging technology to give new insight into the way an aggressive form of lung disease develops in the body.

Siemens Healthcare announced the U.S. Food and Drug Administration (FDA) has cleared two new magnetic resonance imaging (MRI) applications – Simultaneous Multi-Slice (SMS) and GOBrain – designed to dramatically reduce the time required for MRI examinations of the brain.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now